Russia has already approved two COVID-19 vaccines, Sputnik V and EpiVacCorona, which were also granted approval before seeing any late-stage trial results

Six hospitals in England will administer the first of around 530,000 doses Britain has ready

Oxford-AstraZeneca vaccine approved: The world's largest vaccine maker by volume, Serum Institute has already manufactured 50 million doses of Oxford-AstraZeneca vaccine on at-risk funding; the vaccine is cheap and easy to produce

The Oxford vaccine, which also has a tie-up with the Serum Institute of India, is expected to win approval in the UK before Thursday, speeding up the provision of the jab to the most vulnerable groups

The SII CEO says considering the high demand for vaccines in the wake of coronavirus, the next decade could be a \"golden one\" for the entire vaccine industry

World's biggest vaccine maker has already manufactured over 50 million doses; further production will start as soon as it gets necessary approvals in India and the UK. SII is hoping to supply 3 billion doses of vaccine in 2021

In his latest blog post, Bill & Melinda Gates Foundation co-chairman said his foundation has also taken some of the financial risks on the Oxford-AstraZeneca vaccine and that Serum won't have to take a full loss

The applications are being examined on scientific basis, using the frameworks that are scientific, frameworks that are globally aligned and ensuring that the vaccine is safe, NITI Aayog member (health) Dr V K Paul said

Warehouses which use electricity would have difficulty maintaining the -70 degrees Celsius (-94 F) required by the vaccine for storage and carry the risk of the temperature rising during a power blackout, he said

In total, Britain has ordered 40 million doses of the Pfizer/BioNTech shot. As each person requires two doses, that is enough to vaccinate 20 million people in the country of 67 million

It is anticipated that washing machines and air conditioners (ACs) prices may go up by 8-10 per cent, and the rates of refrigerators might witness a spike of 12- 15 per cent

There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute

The import challenges due to the coronavirus pandemic have made it difficult for most brands to get their products into the country this year, resulting in a supply crisis

Advertisement created a stir because COVID-19 vaccine is yet to be rolled out for masses, and Centre is working on a distribution system once vaccine is available

Vardhan says it makes no sense to consider Pfizer as pharma major is yet to get approval in the US. After requisite approvals, US pharma major will have to cater to needs of its own country's population first

Serum Institute has tied up with British-Swedish pharmaceutical firm AstraZeneca and the University of Oxford to mass-produce the Covishield vaccine to fight back COVID-19 virus

Indian Council of Medical Research is working closely with SII for Covishield vaccine trials across 15 centres in India, and would also be funding the clinical trials in the country.

EEPC India vice chairman Arun Garodia says tractors are the largest component of the agri-machinery exports from the country, accounting for 66 per cent of the shipments

High court also rejected prayer by some of acquitted individuals seeking to direct government to place on record documents containing process to be followed before taking a decision to file an appeal

Maharashtra cabinet minister on Monday also said that the state government is contemplating on this matter and might take the final call in the next eight days